Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Non-Current Liabilities (2019 - 2026)

Biodesix filings provide 8 years of Other Non-Current Liabilities readings, the most recent being $860000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 24.28% to $860000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $860000.0, a 24.28% increase, with the full-year FY2025 number at $1.0 million, up 25.28% from a year prior.
  • Other Non-Current Liabilities hit $860000.0 in Q1 2026 for Biodesix, down from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $18.6 million in Q4 2022 to a low of $60000.0 in Q3 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $744000.0 (2024), compared with a mean of $3.6 million.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 99.7% in 2022 and later skyrocketed 17475.71% in 2023.
  • Biodesix's Other Non-Current Liabilities stood at $18.6 million in 2022, then plummeted by 96.18% to $712000.0 in 2023, then rose by 14.47% to $815000.0 in 2024, then increased by 25.28% to $1.0 million in 2025, then decreased by 15.77% to $860000.0 in 2026.
  • The last three reported values for Other Non-Current Liabilities were $860000.0 (Q1 2026), $1.0 million (Q4 2025), and $769000.0 (Q3 2025) per Business Quant data.